These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2884198)

  • 21. Inhibitory effect of reversible serine protease inhibitors on the activity of cytotoxic T lymphocytes.
    Arakawa K; Nakajima H; Yoshida T; Yasumura T; Aikawa I; Ohmori Y; Oka T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1152-3. PubMed ID: 2495591
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of a specific serine protease inhibitor on the rat pancreas. II. Influence of camostate on the endocrine pancreas.
    Göke B; Siegel EG; Stöckmann F; Lankisch PG; Creutzfeldt W
    Digestion; 1985; 31(2-3):128-35. PubMed ID: 3888752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic and pancreatic metabolism and biliary excretion of the protease inhibitor camostat mesilate.
    Beckh K; Weidenbach H; Weidenbach F; Müller R; Adler G
    Int J Pancreatol; 1991; 10(3-4):197-205. PubMed ID: 1787334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of camostat mesilate on puromycin aminonucleoside nephrotic rats.
    Suzuki J; Suzuki S; Nozawa R; Kumaki S; Kume K; Higuchi E; Kamiyama S; Ohara N; Yugeta E; Kato K
    Fukushima J Med Sci; 1988 Jun; 34(1):21-5. PubMed ID: 3254858
    [No Abstract]   [Full Text] [Related]  

  • 25. Elimination of the low-molecular weight proteinase inhibitor camostate (FOY 305) and its degradation products by the rat liver.
    Beckh K; Göke B; Müller R; Arnold R
    Res Exp Med (Berl); 1987; 187(6):401-6. PubMed ID: 3441682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent growth-suppressive activity of a serine protease inhibitor, ONO-3403, toward malignant human neuroblastoma cell lines.
    Hiwasa T; Kondo K; Nakagawara A; Ohkoshi M
    Cancer Lett; 1998 Apr; 126(2):221-5. PubMed ID: 9585070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cirrhosis and carcinoma of the liver in male rats given subcutaneous carbon tetrachloride.
    Reuber MD; Glover EL
    J Natl Cancer Inst; 1970 Feb; 44(2):419-27. PubMed ID: 11515084
    [No Abstract]   [Full Text] [Related]  

  • 28. Diethyl-nitrosamine hepatocarcinogenesis in cirrhotic rats.
    Zalatnai A; Lapis K
    Acta Morphol Hung; 1987; 35(3-4):211-8. PubMed ID: 3137785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative assessment of liver colony formation and hepatocellular carcinoma incidence in rats receiving intravenous injections of isogeneic liver cells isolated during hepatocarcinogenesis.
    Laishes BA; Rolfe PB
    Cancer Res; 1980 Nov; 40(11):4133-43. PubMed ID: 6110475
    [No Abstract]   [Full Text] [Related]  

  • 30. Application of a synthetic serine protease inhibitor in the treatment of DIC.
    Kosaki G; Kambayashi J; Imaoka S
    Bibl Haematol; 1983; (49):317-27. PubMed ID: 6230076
    [No Abstract]   [Full Text] [Related]  

  • 31. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma.
    Chen CL; Wang SD; Zeng ZY; Lin KJ; Kao ST; Tani T; Yu CK; Wang JY
    J Allergy Clin Immunol; 2006 Jul; 118(1):105-12. PubMed ID: 16815145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effects of protease inhibitors on glioma cells in culture].
    Obonai C
    Nihon Gan Chiryo Gakkai Shi; 1988 Aug; 23(8):1720-6. PubMed ID: 2461424
    [No Abstract]   [Full Text] [Related]  

  • 33. High-molecular-weight neutral proteinase of rat ascites hepatoma cells and their collagenolytic activity.
    Maruyama R; Nabeshima K; Ishihara A; Kataoka H; Koono M
    Invasion Metastasis; 1988; 8(5):285-300. PubMed ID: 3058624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth inhibition of mouse skin tumor by serine protease inhibitor ONO-3403.
    Ohkoshi M; Okuda S
    Anticancer Res; 2001; 21(3B):1803-8. PubMed ID: 11497262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibition of platelet aggregation and prevention of endotoxin-induced DIC by a protease inhibitor, FUT-175, in rats].
    Yoshikawa T; Murakami M; Furukawa Y; Onodera H; Yoshida N; Ueda M; Kato H; Takemura S; Sugino S; Kondo M
    Masui; 1984 Apr; 33(4):397-402. PubMed ID: 6471360
    [No Abstract]   [Full Text] [Related]  

  • 36. Improvement in early symptoms of shock by delayed intestinal protease inhibition.
    Fitzal F; DeLano FA; Young C; Schmid-Schönbein GW
    Arch Surg; 2004 Sep; 139(9):1008-16. PubMed ID: 15381622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A leupeptin inactivating enzyme from rat liver.
    Place GA; Ning MC; Beynon RJ
    Prog Clin Biol Res; 1985; 180():269-71. PubMed ID: 3898100
    [No Abstract]   [Full Text] [Related]  

  • 38. Enhancement of proteinase activities by bradykinin in adrenal medulla of the rat.
    Wei EQ; Kudo T; Inoki R
    Adv Exp Med Biol; 1989; 247B():633-8. PubMed ID: 2692419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of calcium ion-dependent proteinases by bradykinin in dental pulp of the rat.
    Kudo T; Wei EQ; Inoki R
    Adv Exp Med Biol; 1989; 247B():627-31. PubMed ID: 2558523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents: implications in peptide delivery to the colon.
    Tozaki H; Emi Y; Horisaka E; Fujita T; Yamamoto A; Muranishi S
    J Pharm Pharmacol; 1997 Feb; 49(2):164-8. PubMed ID: 9055189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.